Author

Wenjun Ouyang 1

1 Department of Immunology,Genentech,South San Francisco,United States

CROSS-SPECIES TRANSLATABILITY OF NONCLINICAL SAFETY ASSESSMENTS OF A HUMAN INTERLEUKIN-22FC, AN IG FUSION PROTEIN FOR THE POTENTIAL TREATMENT OF INFECTIOUS OR INFLAMMATORY DISEASES

Donna W. Lee, Shelly Zhong, Rama Pai, Estelle Doudement, Eric Stefanich, Julie Rae, Johnny Gutierrez, Jeff Lutman, Xiaoting Wang, Annemarie Lekkerkerker, Julia Qiu, Kelly Loyet, Ann Herman, Wenjun Ouyang, Mary E. Keir, Dimitry Danilenko

INTERLEUKIN-22 IS A CRITICAL MEDIATOR OF VACCINE-INDUCED REDUCTION OF HELICOBACTER INFECTION IN THE MOUSE MODEL

Mati Moyat, Hanifa Bouzourene, Wenjun Ouyang, Jean-Christophe Renauld, Dominique Velin

PRE-CLINICAL PHARMACOLOGY FOR A HUMAN INTERLEUKIN-22 IG FUSION PROTEIN FOR THE POTENTIAL TREATMENT OF INFECTIOUS OR INFLAMMATORY DISEASES

Eric Stefanich, Julie Rae, Jeff Lutman, Xiaoting Wang, Annemarie Lekkerkerker, Wenjun Ouyang, Julia Qiu, Donna W. Lee, Dimitry Danilenko, Kelly Loyet, Mary E. Keir, Siddharth Sukumaran, Ann Herman

Item 1 - 3 / 3
1